COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States is a research paper published in EClinicalMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DP2HD084068
American Cancer Society
Grant: 1UL1TR002548-01
Clinical and Translational Science Collaborative of Cleveland
American Cancer Society
Grant: RSG-16-049-01 \u2013 MPC
American Cancer Society
Grant: RSG-16-049-01
NIA NIH HHS
Grant: R56 AG062272
NCRR NIH HHS
Grant: UL1 RR024989
NIAAA NIH HHS
Grant: R01 AA029831
NIA NIH HHS
Grant: R01 AG061388
NIA NIH HHS
Grant: RF1 AG076649
NCATS NIH HHS
Grant: UL1 TR002548
NIA NIH HHS
Grant: R01 AG057557
NCATS NIH HHS
Grant: UL1 TR000439
National Institutes of Health
Grant: 5R01AG057557-05
An Integrated Reverse Engineering Approach Toward Rapid drug Re positioning for Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG061388-02
Combine computational prediction, network analysis and genetic screening in C elegans to uncover neurodegenerative causes in Alzheimer's Disease
National Institutes of Health
Grant: 1DP2HD084068-01
Rapid reverse translational drug repositioning
National Institutes of Health
Grant: 5R56AG062272-02
Construct large-scale phenomes of disease and drugs and develop data-driven systems approaches to understand genetic links between Alzheimer's disease and Neuropsychiatric symptoms
National Institutes of Health
American Cancer Society
FWCI
1.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals